DR. FREDERICK L. BAEHNER, MD
Medical Practice at Parnassus Ave, San Francisco, CA
License number
California A68894
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
505 Parnassus Ave, San Francisco, CA 94143
Phone
(415) 353-1163
(415) 353-1618 (Fax)
(415) 476-4029
(415) 476-4150 (Fax)
(415) 353-1618 (Fax)
(415) 476-4029
(415) 476-4150 (Fax)
Personal information
See more information about FREDERICK L. BAEHNER at radaris.comName
Address
Phone
243 Oconnor St, Menlo Park, CA 94025
54 Kissling St, San Francisco, CA 94103
243 Oconnor St, Menlo Park, CA 94025
54 Kissling St, San Francisco, CA 94103
3817 Kirkwood Ave, Riverside, CA 92501
Professional information
See more information about FREDERICK L. BAEHNER at trustoria.com
Frederick Lee Baehner, San Francisco CA
Frederick Lee Baehner, San Francisco CA
Specialties:
Pathology, Cytopathology, Anatomic Pathology & Clinical Pathology, Hematology, Surgery
Work:
UCSF Medical Center / Moffitt-Long Hospitals
1600 Divisadero St, San Francisco, CA 94115
1600 Divisadero St, San Francisco, CA 94115
Education:
University of Kansas(1997)
Dr. Frederick L Baehner, San Francisco CA - MD (Doctor of Medicine)
Dr. Frederick L Baehner, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Cytopathology
Address:
505 Parnassus Ave, San Francisco 94143
(415) 353-1163 (Phone), (415) 353-1618 (Fax)
1600 Divisadero St SUITE R200, San Francisco 94115
(415) 885-7586 (Phone), (415) 353-7676 (Fax)
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
(415) 476-9000 (Phone)
(415) 353-1163 (Phone), (415) 353-1618 (Fax)
1600 Divisadero St SUITE R200, San Francisco 94115
(415) 885-7586 (Phone), (415) 353-7676 (Fax)
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
(415) 476-9000 (Phone)
Certifications:
Anatomic & Clinical Pathology, 2003, Cytopathology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
505 Parnassus Ave, San Francisco 94143
1600 Divisadero St SUITE R200, San Francisco 94115
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
1600 Divisadero St SUITE R200, San Francisco 94115
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
Education:
Medical School
University of Kansas / School of Medicine
Graduated: 1996
University Ca Sf School Of Med
University of Kansas / School of Medicine
Graduated: 1996
University Ca Sf School Of Med
Frederick L Baehner, San Francisco CA
Frederick L Baehner, San Francisco CA
Specialties:
Pathologist
Address:
505 Parnassus Ave, San Francisco, CA 94143
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology), American Board of Pathology Sub-certificate in Cytopathology (Pathology)
Method To Use Gene Expression To Determine Likelihood Of Clinical Outcome Of Renal Cancer
Method To Use Gene Expression To Determine Likelihood Of Clinical Outcome Of Renal Cancer
US Patent:
2011017, Jul 14, 2011
Filed:
Jan 7, 2011
Appl. No.:
12/987023
Inventors:
Wayne Cowens - Tiburon CA, US
Steven Shak - Hillsborough CA, US
Audrey Goddard - San Francisco CA, US
Dejan Knezevic - Palo Alto CA, US
Joffre B. Baker - Montara CA, US
Michael C. Kiefer - Clayton CA, US
Tara Maddala - Sunnyvale CA, US
Frederick L. Baehner - San Francisco CA, US
Steven Shak - Hillsborough CA, US
Audrey Goddard - San Francisco CA, US
Dejan Knezevic - Palo Alto CA, US
Joffre B. Baker - Montara CA, US
Michael C. Kiefer - Clayton CA, US
Tara Maddala - Sunnyvale CA, US
Frederick L. Baehner - San Francisco CA, US
International Classification:
C12Q 1/68, C12Q 1/02, G01N 33/68
US Classification:
435 61, 435 29, 436 86
Abstract:
The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.
Method For Using Gene Expression To Determine Prognosis Of Prostate Cancer
Method For Using Gene Expression To Determine Prognosis Of Prostate Cancer
US Patent:
2012002, Feb 2, 2012
Filed:
Jul 25, 2011
Appl. No.:
13/190391
Inventors:
Steven Shak - Hillsborough CA, US
Frederick L. Baehner - San Francisco CA, US
Tara Maddala - Sunnyvale CA, US
Mark Lee - Los Altos Hills CA, US
Robert J. Pelham - Belmont CA, US
Wayne Cowens - Tiburon CA, US
Diana Cherbavaz - San Francisco CA, US
Michael C. Kiefer - Walnut Creek CA, US
Michael Crager - Menlo Park CA, US
Audrey Goddard - San Francisco CA, US
Joffre B. Baker - Montara CA, US
Frederick L. Baehner - San Francisco CA, US
Tara Maddala - Sunnyvale CA, US
Mark Lee - Los Altos Hills CA, US
Robert J. Pelham - Belmont CA, US
Wayne Cowens - Tiburon CA, US
Diana Cherbavaz - San Francisco CA, US
Michael C. Kiefer - Walnut Creek CA, US
Michael Crager - Menlo Park CA, US
Audrey Goddard - San Francisco CA, US
Joffre B. Baker - Montara CA, US
International Classification:
C12Q 1/68
US Classification:
435 614, 435 61, 435 618, 435 617
Abstract:
Molecular assays that involve measurement of expression levels of prognostic biomarkers, or co-expressed biomarkers, from a biological sample obtained from a prostate cancer patient, and analysis of the measured expression levels to provide information concerning the likely prognosis for said patient, and likelihood that said patient will have a recurrence of prostate cancer, or to classify the tumor by likelihood of clinical outcome or TMPRSS2 fusion status, are provided herein.
Method For Determining The Likelihood Of Response To Her2 Inhibitors
Method For Determining The Likelihood Of Response To Her2 Inhibitors
US Patent:
2010015, Jun 17, 2010
Filed:
Sep 4, 2009
Appl. No.:
12/554783
Inventors:
Frederick L. Baehner - San Francisco CA, US
Drew Watson - Los Altos CA, US
Tara Maddala - Redwood City CA, US
Steve Shak - Hillsborough CA, US
Robert Gray - Boston MA, US
Joseph Sparano - Pleasantville NY, US
Drew Watson - Los Altos CA, US
Tara Maddala - Redwood City CA, US
Steve Shak - Hillsborough CA, US
Robert Gray - Boston MA, US
Joseph Sparano - Pleasantville NY, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present disclosure provides methods for determining the HER2 Status of a cancer tumor sample.